These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 17530993

  • 1. Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India.
    Kurle SN, Gangakhedkar RR, Sen S, Hayatnagarkar SS, Tripathy SP, Paranjape RS.
    AIDS Res Hum Retroviruses; 2007 May; 23(5):682-5. PubMed ID: 17530993
    [Abstract] [Full Text] [Related]

  • 2. Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.
    Persaud D, Bedri A, Ziemniak C, Moorthy A, Gudetta B, Abashawl A, Mengistu Y, Omer SB, Isehak A, Kumbi S, Adamu R, Lulseged S, Ashworth R, Hassen E, Ruff A, Ethiopian Swen Study Team.
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):823-9. PubMed ID: 21241214
    [Abstract] [Full Text] [Related]

  • 3. Characterization of nevirapine (NVP) resistance mutations and HIV type 1 subtype in women from Abidjan (Côte d'Ivoire) after NVP single-dose prophylaxis of HIV type 1 mother-to-child transmission.
    Toni TD, Masquelier B, Lazaro E, Dore-Mbami M, Ba-Gomis FO, Téa-Diop Y, Kouakou K, Diby J, Sia E, Soppi S, Essien S, Schrive MH, Pinson P, Chenal H, Fleury HJ.
    AIDS Res Hum Retroviruses; 2005 Dec; 21(12):1031-4. PubMed ID: 16379606
    [Abstract] [Full Text] [Related]

  • 4. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
    Samuel R, Paredes R, Parboosing R, Moodley P, Singh L, Naidoo A, Gordon M.
    J Med Virol; 2015 Oct; 87(10):1662-7. PubMed ID: 25940687
    [Abstract] [Full Text] [Related]

  • 5. Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: population and clonal sequence analysis.
    Kassaye S, Lee E, Kantor R, Johnston E, Winters M, Zijenah L, Mateta P, Katzenstein D.
    AIDS Res Hum Retroviruses; 2007 Aug; 23(8):1055-61. PubMed ID: 17725424
    [Abstract] [Full Text] [Related]

  • 6. Nevirapine resistance after single dose prophylaxis.
    Eshleman SH, Jackson JB.
    AIDS Rev; 2002 Aug; 4(2):59-63. PubMed ID: 12152519
    [Abstract] [Full Text] [Related]

  • 7. Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
    Jones D, Parkin N, Hudelson SE, Guay LA, Musoke P, Mmiro F, Jackson JB, Eshleman SH.
    AIDS Res Hum Retroviruses; 2005 Apr; 21(4):319-24. PubMed ID: 15943576
    [Abstract] [Full Text] [Related]

  • 8. HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda.
    Servais J, Lambert C, Karita E, Vanhove D, Fischer A, Baurith T, Schmit JC, Schneider F, Hemmer R, Arendt V.
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):279-83. PubMed ID: 15117451
    [Abstract] [Full Text] [Related]

  • 9. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
    Eshleman SH, Mracna M, Guay LA, Deseyve M, Cunningham S, Mirochnick M, Musoke P, Fleming T, Glenn Fowler M, Mofenson LM, Mmiro F, Jackson JB.
    AIDS; 2001 Oct 19; 15(15):1951-7. PubMed ID: 11600822
    [Abstract] [Full Text] [Related]

  • 10. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.
    Han J, Wang L, Jiang Y, Zhang Q, Fang L, Yao J, Wang Q.
    Int J STD AIDS; 2009 Apr 19; 20(4):249-54. PubMed ID: 19304969
    [Abstract] [Full Text] [Related]

  • 11. Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA.
    Bannister WP, Ruiz L, Cozzi-Lepri A, Mocroft A, Kirk O, Staszewski S, Loveday C, Karlsson A, Monforte Ad, Clotet B, Lundgren JD, EuroSIDA study group.
    AIDS; 2008 Jan 30; 22(3):367-76. PubMed ID: 18195563
    [Abstract] [Full Text] [Related]

  • 12. Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.
    van Zyl GU, Claassen M, Engelbrecht S, Laten JD, Cotton MF, Theron GB, Preiser W.
    J Med Virol; 2008 Jun 30; 80(6):942-6. PubMed ID: 18428139
    [Abstract] [Full Text] [Related]

  • 13. Characterization of HIV type 1 reverse transcriptase mutations in infants infected by mothers who received peripartum nevirapine prophylaxis in Jos, Nigeria.
    Ojesina AI, Mullins C, Imade G, Samuels J, Sankalé JL, Pam S, Sagay S, Idoko J, Kanki PJ.
    AIDS Res Hum Retroviruses; 2007 Dec 30; 23(12):1587-92. PubMed ID: 18160018
    [Abstract] [Full Text] [Related]

  • 14. Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine.
    Flys TS, Mwatha A, Guay LA, Nakabiito C, Donnell D, Musoke P, Mmiro F, Jackson JB, Eshleman SH.
    AIDS; 2007 Oct 01; 21(15):2077-82. PubMed ID: 17885298
    [Abstract] [Full Text] [Related]

  • 15. Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.
    Eshleman SH, Guay LA, Mwatha A, Cunningham SP, Brown ER, Musoke P, Mmiro F, Jackson JB.
    AIDS Res Hum Retroviruses; 2004 Jun 01; 20(6):595-9. PubMed ID: 15242535
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.
    Arrivé E, Newell ML, Ekouevi DK, Chaix ML, Thiebaut R, Masquelier B, Leroy V, Perre PV, Rouzioux C, Dabis F, Ghent Group on HIV in Women and Children.
    Int J Epidemiol; 2007 Oct 01; 36(5):1009-21. PubMed ID: 17533166
    [Abstract] [Full Text] [Related]

  • 17. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J, Yue J, Wu S, Yan Y.
    Arch Virol; 2007 Oct 01; 152(10):1799-805. PubMed ID: 17619115
    [Abstract] [Full Text] [Related]

  • 18. Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.
    Pilger D, Hauser A, Kuecherer C, Mugenyi K, Kabasinguzi R, Somogyi S, Harms G, Kunz A.
    Antivir Ther; 2011 Oct 01; 16(1):109-13. PubMed ID: 21311114
    [Abstract] [Full Text] [Related]

  • 19. Variability in the plasma concentration of efavirenz and nevirapine is associated with genotypic resistance after treatment interruption.
    Darwich L, Esteve A, Ruiz L, Bellido R, Clotet B, Martinez-Picado J.
    Antivir Ther; 2008 Oct 01; 13(7):945-51. PubMed ID: 19043929
    [Abstract] [Full Text] [Related]

  • 20. Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients.
    Rajesh L, Karunaianantham R, Narayanan PR, Swaminathan S.
    AIDS Res Hum Retroviruses; 2009 Nov 01; 25(11):1179-85. PubMed ID: 19895208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.